Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties.
| Revenue (TTM) | $25.27B |
| Gross Profit (TTM) | $16.35B |
| EBITDA | $6.92B |
| Operating Margin | 17.80% |
| Return on Equity | 15.20% |
| Return on Assets | 7.72% |
| Revenue/Share (TTM) | $66.06 |
| Book Value | $58.61 |
| Price-to-Book | 5.03 |
| Price-to-Sales (TTM) | 4.41 |
| EV/Revenue | 4.962 |
| EV/EBITDA | 19.74 |
| Quarterly Earnings Growth (YoY) | 14.20% |
| Quarterly Revenue Growth (YoY) | 2.60% |
| Shares Outstanding | $382.98M |
| Float | $346.74M |
| % Insiders | 5.37% |
| % Institutions | 82.24% |
Volatility is currently expanding